Abiopharma

Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer

Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026

Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive

IAMGOLD CORP (IAG) Files Form 6-K

(99% Neutral) HYCROFT MINING HOLDING CORP (HYMC) Files Form 8-K

CoyaTherapeutics - Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director

(99% Neutral) VEEA INC. (VEEA) Announces Business Combination

Emergent BioSolutions Participates in Upcoming International Preparedness Conferences

LightInTheBox Files 2025 Annual Report on Form 20-F

Fusion Fuel Highlights Fiscal Year 2025 Results and Business Progress of Majority-Owned Subsidiary Quality Industrial Corp.; Achieves 45.9% Year-Over-Year Revenue Growth to $16.3 Million

Finance of America Introduces HomeSafe Second Line of Credit, Unlocking Flexible Access to Home Equity – Without Monthly Mortgage Payments

Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director

Visa Defines the Next Era of Commerce: When AI Becomes the Customer

AAON Announces CFO Transition and Strengthens Executive Leadership Team

High Roller Technologies Regains Compliance with NYSE American Continued Listing Standards